What it is
Semaglutide is a GLP-1 receptor agonist — a class of medications originally developed for type 2 diabetes that have been shown to support meaningful weight loss in patients who meet specific criteria. When prescribed and monitored within a structured medical program, semaglutide reduces appetite, slows gastric emptying, and supports caloric restriction without the white-knuckle effort of willpower alone.
How we approach it
This is a medical program, not a weight-loss product. The first visit is a real medical evaluation — history, BMI, prior weight history, current medications, contraindications, blood work. We discuss your goals candidly, including whether semaglutide is the right tool for you.
Monthly follow-up is standard. Dose titration is gradual to mitigate GI side effects. Nutrition, hydration, and movement habits are part of the conversation at every visit — the medication is a tool that works best paired with the habits.
The program is open to patients who meet criteria and who can commit to the monthly cadence.
What to expect
After medical clearance, the medication is started at a low dose and titrated upward over weeks. Early side effects (nausea most commonly) typically resolve within the first month and respond to dose adjustment.
Weight changes are gradual — meaningful loss over months, not weeks. Follow-up labs are scheduled per the program protocol.
Candidacy
Eligibility is determined at the initial medical visit and includes BMI criteria, contraindication screening, and the candor of the conversation about goals. Not appropriate during pregnancy, breastfeeding, or for patients with a personal or family history of medullary thyroid carcinoma or MEN-2. History of pancreatitis requires clearance.
If semaglutide is not appropriate for you, the clinician will say so and discuss alternatives.